Inventor · disambiguated record
John H. Lee
Also filed as: LEE JOHN · LEE JOHN H · LEE JOHN H S · LEE JOHN HENRY
35 granted patents·49 pending applications·280 citations·filing 1975–2025
97Inventor score
Top patents by PatentIndex Score
84 records- 0197US11230699B2Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptorsNANTKWEST INC·Filed 2020·Granted Jan 25, 2022·9 cites·27 claims
- 0296US11071751B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2020·Granted Jul 27, 2021·5 cites·20 claims
- 0395US10960024B2Quadricistronic system comprising a homing receptor and chimeric antigen receptor for stable genetic modification of cellular immunotherapiesNANTKWEST INC·Filed 2019·Granted Mar 30, 2021·17 cites·18 claims
- 0493US11857567B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2021·Granted Jan 2, 2024·2 cites·22 claims
- 0593US10709732B2Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2019·Granted Jul 14, 2020·6 cites·33 claims
- 0693US4050834AInternally powered traffic control deviceMINNESOTA MINING & MFG·Filed 1976·Granted Sep 27, 1977·63 cites·14 claims
- 0790US12365874B2Chimeric antigen receptor-modified NK-92 cells targeting EGFR super-family receptorsIMMUNITYBIO INC·Filed 2021·Granted Jul 22, 2025·1 cites·18 claims
- 0889US11690870B2Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2020·Granted Jul 4, 2023·2 cites·10 claims
- 0988US11909911B2System for centralized captioned telephone serviceMEZMO CORP·Filed 2021·Granted Feb 20, 2024·3 cites·16 claims
- 1086US11311603B2HIV treatment compositions and methodsNANTCELL INC·Filed 2019·Granted Apr 26, 2022·2 cites·15 claims
- 1185US12303477B2HIV treatment compositions and methodsNANTCELL INC·Filed 2023·Granted May 20, 2025·0 cites·14 claims
- 1285US10813947B1Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2019·Granted Oct 27, 2020·5 cites·7 claims
- 1383US2024350533A1Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1480US9911160B2Tax payment system and method for accurate paymentsLEE JOHN H·Filed 2015·Granted Mar 6, 2018·3 cites·1 claims
- 1579US6368657B1Precipitation recovery process for food waste sludgeRIGEL TECHNOLOGY CORP·Filed 2001·Granted Apr 9, 2002·10 cites·9 claims
- 1678US2025381219A1Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agentDECIBEL THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1777US12244764B2Captioned telephone service system for providing original number service and anti-spam functionMEZMO CORP·Filed 2022·Granted Mar 4, 2025·1 cites·20 claims
- 1877US11786577B2HIV treatment compositions and methodsNANTCELL INC·Filed 2021·Granted Oct 17, 2023·0 cites·20 claims
- 1977US2025255840A1HIV Treatment Compositions And MethodsNANTCELL INC·Filed 2025·Application pending·0 cites
- 2076US11902466B2Captioned telephone service system having text-to-speech and answer assistance functionsMEZMO CORP·Filed 2022·Granted Feb 13, 2024·1 cites·19 claims
- 2176US9556113B2Combination uses of dichloroacetate and oxamate, and their prodrugs, for cancer treatmentTHE SOUTH DAKOTA BOARD OF REGENTS·Filed 2015·Granted Jan 31, 2017·5 cites·5 claims
- 2276US2024252540A1Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironmentIMMUNITYBIO INC·Filed 2024·Application pending·0 cites
- 2375US3986719APortable ball targetLEE JOHN HENRY·Filed 1975·Granted Oct 19, 1976·39 cites·4 claims
- 2474US2024226141A9Methods of otoprotection against platinum-based antineoplastic agentsDECIBEL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2572USD505729SSlope electrophoresisRIGEL TECHNOLOGY CORP·Filed 2003·Granted May 31, 2005·20 cites·1 claims
- 2668US2025154465A1Chimeric antigen receptor-modified nk-92 cells targeting egfr super-family receptorsIMMUNITYBIO INC·Filed 2025·Application pending·0 cites
- 2767US11992504B2Cell-mediated transient delivery of immune-enhancing molecules into the tumor microenvironmentIMMUNITYBIO INC·Filed 2020·Granted May 28, 2024·0 cites·11 claims
- 2867US4145617AControl circuit for providing time selected application of A.C. powerMINNESOTA MINING & MFG·Filed 1977·Granted Mar 20, 1979·13 cites·9 claims
- 2967US2021284716A1ACE2-Fc TrapIMMUNITYBIO INC·Filed 2020·Application pending·0 cites
- 3066US2024309399A1Methods and compositions for administering otoferlin dual vector systemsDECIBEL THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3165US2024424458A1Novel mixer for emulsion productsILLINOIS TOOL WORKS·Filed 2024·Application pending·0 cites
- 3264US11318189B1IL-15 agonist drug combinations for immune therapyNANTCELL INC·Filed 2021·Granted May 3, 2022·0 cites·26 claims
- 3364US5168123AChemical initiation of detonation in fuel-air explosive cloudsCA MINISTER NAT DEFENCE·Filed 1990·Granted Dec 1, 1992·21 cites·13 claims
- 3464US2022273722A1Anti-egfr/high affinity nk-cells compositions and methods for chordoma treatmentIMMUNITY BIO INC·Filed 2022·Application pending·0 cites
- 3562US2015196046A1Animal Feed CompositionLEE JOHN·Filed 2014·Application pending·0 cites
- 3660US8092987B2Mucosa tissue preserved with heating and hydrogen peroxide or phosphoric acidLEE JOHN H·Filed 2006·Granted Jan 10, 2012·1 cites·5 claims
- 3760US2023192895A1Pharmacokinetic & pharmacodynamic model for determining effective dose of anti-ticagrelor antibodyPHASEBIO PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3857USD542644SProtection screw for a vehicle license plateRIGEL TECHNOLOGY CORP·Filed 2005·Granted May 15, 2007·11 cites·1 claims
- 3957US2007190116A1Solid calcium bolus product with quick dissolutionRIGEL TECHNOLOGY CORP·Filed 2007·Application pending·0 cites
- 4056US4975098ALow pressure drop detonation arrestor for pipelinesLEE JOHN H S·Filed 1988·Granted Dec 4, 1990·28 cites·23 claims
- 4155US2023173030A1Vasoactive intestinal peptide fusion proteins for the treatment of covid-19PHASEBIO PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4254US2022054640A1Compositions and methods for the delivery of therapeutic agents across the round window membraneDECIBEL THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4354US2020155599A1Anti-egfr/high affinity nk-cells compositions and methods for chordoma treatmentNANTKWEST INC·Filed 2018·Application pending·0 cites
- 4454US2021188933A1Methods of treating pancytopeniaNANTCELL INC·Filed 2020·Application pending·0 cites
- 4554US2021169931A1Screening of cell clones expressing polygenic transgenes through non-antibiotic dependent positive selectionNANTKWEST INC·Filed 2020·Application pending·0 cites
- 4653US2021106619A1NK-92 Bone and Brain targetingNANTKWEST INC·Filed 2020·Application pending·0 cites
- 4752US7446215B2Solid fat products from some liquid oil ingredientsRIGEL TECHNOLOGY CORP·Filed 2004·Granted Nov 4, 2008·2 cites·14 claims
- 4852US2022218789A1Nogapendekin Alfa-Inbakicept For Immune Stimulant Therapies And Treatment Of Viral InfectionsNANT HOLDINGS IP LLC·Filed 2020·Application pending·0 cites
- 4951US9492526B2Polynucleotides for treating oncogenic viral polypeptide positive tumorsSANFORD HEALTH·Filed 2013·Granted Nov 15, 2016·0 cites·15 claims
- 5051US2013204758A1Novel tax simplification table product for tax rate and tax calculationsLEE JOHN H·Filed 2012·Application pending·0 cites
Showing the top 50 of 84 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John H. Lee files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →